Yunnan Watson Biotechnology Co., Ltd. chooses contract lock

Recently, Yunnan Watson Biotechnology Co., Ltd. chose Contract Lock and established a digital trust foundation by deploying an electronic signature and seal management platform, making the digital process trustworthy; Effective· Security· Verifiable· Check it out! Yunnan Watson Biotechnology Co., Ltd. was established in 2001. After more than 20 years of development, it has become a modern high-tech biopharmaceutical enterprise specializing in the research and development, production, and sales of human vaccines and other biotechnology drugs in China. The company has built a leading domestic vaccine research and industrialization technology platform, gathering a large number of professional technical and management talents who combine Chinese and Western styles, and has won a number of national awards; 863 Program; And“ Major New Drug Creation; Supported by major technology projects, we have established close cooperative relationships with multiple domestic research institutes, universities, and internationally renowned institutions such as the Gates Foundation. At present, the product sales cover 31 provinces and cities across the country, and are exported to 18 countries overseas. The company's AC polysaccharide vaccine has been included in the national expanded immunization program by the Egyptian government for five consecutive years since 2018 due to its excellent quality; The export of the 13 valent pneumococcal conjugate vaccine to Morocco in May 2022 is a milestone event in the internationalization process of China's vaccine industry. The vaccine has been included in Morocco's expanded immunization program to protect millions of children from life-threatening diseases.   Along with its rapid development, the company has put forward new digital requirements for business management and daily office operations. Yunnan Watson Biotechnology Co., Ltd. has chosen Contract Lock this time, which provides a trustworthy foundation for the organization's digital construction through the Contract Lock Digital Trusted Platform.

Contract locks support the printing and signing needs of the core business of the pharmaceutical industry:

Help the pharmaceutical industry build an electronic printing control platform and fully realize the“ Electronic seal+physical seal” Unified control, integrated with ERP, OA, CRM, and SRM supplier management software, enables pharmaceutical enterprises to easily call contract lock electronic signatures in the process flow of various businesses, promoting the development of; Drug registration, production, testing, and distribution; Waiting for business documents to be implemented; Online approval, stamping, signing, verification, and retention; Assist pharmaceutical companies in achieving digital transformation. Click to enter and try it for free now!

span style='box-sizing: border-box; -webkit-tap-highlight-color: transparent; color: rgb(76, 89, 110); font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space:normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: PingFangSC-Regular, "PingFang SC"; background-color: rgb(255, 255, 255); float: none; display: inline ! important; '>